A clinical observation of TGP combined with glucocorticoids in the treatment of OLP showed that TGP is a safe and effective drug with few side effects in the treatment of OLP
Today, approximately 50% of all HF patients demonstrate preserved ejection fraction, and the prevalence of this condition continues to increases annually
These findings align with emerging research on GLP-1RAs as novel pharmacotherapies for AUD, a condition with limited effective treatments [33]
The American Society of Anesthesiologists (ASA) released initial consensus-based guidance in June 2023, recommending medication cessation: daily dosing held on the day of procedure and weekly dosing held one week prior [9]
Because the goal of such treatments is to suppress pigment production systemically, the hair follicles can be affected alongside the skin
Apply gently to the face and body, focusing on darker areas